Ontario Expands Access to COVID-19 Antivirals As Canada's Top Doctor 'Strongly Recommends" Masking Indoors
/Ontario's chief medical officer of health, Dr. Kieran Moore, updated the public on Monday about how the province is managing COVID-19 and the expanding access to antivirals at announced Queen’s Park on Monday afternoon.
Moore thanked the public for continuing to adopt the public health measures in place and strongly recommended to continue wearing a mask indoors. He stated the province will not be reintroducing a mask mandate at this time but to be prepared for those measures to return if a new variant of concern emerges or if the healthcare system is threatened due to rising cases.
“I ask everyone across Ontario to continue doing their part to keep their communities and loved ones safe by staying up to date on vaccinations and wearing masks,” said Moore. “I am pleased that we will be able to offer more accessible antiviral treatment options to more people across Ontario.”
Effective immediately, the following higher-risk groups are eligible to be tested and assessed for antiviral treatments such as Paxlovid, in Ontario:
Individuals aged 18 and over who are immunocompromised (have an immune system that is weakened by a health condition or medications);
Individuals aged 70 and over;
Individuals aged 60 and over with fewer than three vaccine doses; and
Individuals aged 18 and over with fewer than three vaccine doses and at least one risk condition (e.g., a chronic medical condition)